Katy Palmer Joins KJT as Strategic Accounts, SVP

Katy Palmer Joins KJT as Strategic Accounts, SVP

We are delighted to welcome Katy Palmer, PhD as our new Strategic Accounts, SVP, at KJT. With a rich background in executive leadership and over two decades of experience in life science commercial insights, Katy brings a unique blend of strategic thinking, business acumen, and scientific expertise to our team. Having demonstrated remarkable leadership skills in business development and fostering cohesive work environments, Katy’s people-first approach will undoubtedly elevate our team.

With a profound commitment to client satisfaction, Katy will spearhead our Strategic Account Team, ensuring that our clients, both existing and prospective, benefit from the true essence of collaboration and excellence that defines KJT. Her deep-rooted passion for medical innovation, backed by a comprehensive understanding of research methodologies and customer-centric principles, will steer us towards greater success in the healthcare insights industry.

Katy earned her doctorate in immunology and infectious disease from Washington University in St. Louis and her BA in Biology from Lake Forest College, solidifying her academic prowess in the field. We look forward to the impactful contributions she will make to our organization.

“We are thrilled to have Katy join the Leadership Team at KJT given her decades of experience supporting pharmaceutical brands. Her scientific background coupled with research expertise is an exceptional match for our team and we look forward to our employees and clients benefitting from working with her. In these early days, she has already demonstrated a strong command of our clients’ business challenges and how KJT solutions can afford them more confidence in their business decisions,” said Michaela Gascon, President and CEO of KJT.

Blogs & News

Read More
Read More

Empathy, Integrity, and Mindfulness: The Values that Drive Innovation at KJT 

We are immensely proud of our journey from a nascent market research firm in 2007 to a recognized…

Read More
Read More

Generative AI Message Testing – Does it Really Work? 

Message testing is a crucial process for pharmaceutical and biotech companies when evaluating the…

Read More
healthcare provider using generative AI tools
Read More

Using Generative AI for Patient-Centered Market Research – Reality or Myth? 

No matter where you look, generative AI is becoming commonplace. In the realm of healthcare…

Read More
Read More

3 Reasons Why Working in an ESOP Company is Inspiring

When I first came to the United States from Scotland, I wasn’t fully familiar with the idea of…

Read More
Read More

KJT Welcomes Laura McCormick, PhD

KJT is delighted to announce the appointment of Laura McCormick, PhD as the new Vice President of…

Read More
Read More

Finding the Path to Your Brand’s North Star: The Importance of Enhancing Brand Equity & Tracking Research

In the competitive pharmaceutical and biotech landscapes, the strength of a brand can often be the…

Read More
Read More

KJT Welcomes Melissa Usseglio, Senior Vice President of Client Strategy

KJT is thrilled to announce the hiring of Melissa Usseglio as Senior Vice President of Client…

Read More
Read More

Uncovering the Realities of Rare Disorders from the Patient’s Perspective

The world of rare diseases and the impact it has on countless lives is often underestimated. Rare…

Read More
Elderly lady with nurse
Read More

4 Ways to Enhance Care for Patients with Rare Diseases

The unique value of integrating the patient voice into the development process of therapies…

Read More
Read More

Using Evidence from the Exam Room to Shape RWE Strategy

Traditional methods for generating real-world evidence (RWE) from patient-physician conversations…

Let’s Take Research Further. Together.